<DOC>
	<DOCNO>NCT02948062</DOCNO>
	<brief_summary>The goal single institution study evaluate boy adrenoleukodystrophy ( ALD ) diagnose early life , prospectively monitor determine parameter facilitate early detection childhood cerebral form disease . These at-risk subject assess yearly travel University Minnesota , plasma cerebral spinal fluid ( CSF ) biomarker study , MRI base image neuropsychological assessment perform University Minnesota Masonic Children 's Hospital Clinics . The MRI lumbar puncture obtain CSF obtained sedation . In addition , intervene 6 month interval information obtain remotely , include survey MRI 's home location . Also time blood sample obtain locally ship University Minnesota study . There therapeutic intent study .</brief_summary>
	<brief_title>Early Diagnosis Of Childhood Cerebral ALD</brief_title>
	<detailed_description />
	<mesh_term>Adrenoleukodystrophy</mesh_term>
	<criteria>Boys confirm adrenoleukodystrophy , determine long chain fatty acid ( VLCFA ) analysis and/or genotyping . Genotyping necessary diagnosis . Between 1 5 year age , inclusive time consent . Able undergo sedation English primary language household , maximize consistency neuropsychological/developmental testing . Voluntary write parental/guardian consent Evidence cerebral disease time enrollment patient 3 year age must MRI within 4 month sign consent confirm evidence cerebral disease Inability unwillingness travel University Minnesota year duration study Evidence cerebral disease standard T2/FLAIR MRI . If subject develop cerebral ALD study , come study , anticipate would consider transplantation .</criteria>
	<gender>Male</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>ALD</keyword>
	<keyword>Newborn Screening</keyword>
</DOC>